Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 77 clinical trials
Program_Formal_v6.14.formal1  

In severe cases, acne may lead to permanent scarring. Cysts are lumps under the skin that have pus and other tissue in them, but do not come to a head like pimples do. They can cause scarring, blotchy, uneven skin colour and pitting.

  • 0 views
  • 09 Feb, 2025
Featured trial
Safety and Preliminary Efficacy of Combination Therapy for the Treatment of Acne Vulgaris

Acne vulgaris is a multifactorial, highly prevalent dermatologic condition that results in visible lesions that can be quite disfiguring. Consequently, individuals with acne often suffer from a wide range of psychological manifestations.

  • 0 views
  • 02 Jul, 2024
  • 2 locations
Featured trial
Skin Hydration in Persons With Acne After Dietary Supplementation With Botanical Antioxidants (KIWIBOOSTER)

This study aims to assess whether the botanical dietary supplement 'Halo Beauty Kiwi Booster' (HBKB), taken orally daily for 8 weeks, can assist with Acne vulgaris as well as skin hydration and quality of life for those with acne.

  • 0 views
  • 02 Jul, 2024
  • 2 locations
Featured trial
Moisturizer Containing Licochalcone A, Decanediol, L-carnitine and Salicylic Acid in Reducing Relapsing of Acne  

Moisturizer containing the active ingredients of licochalcone A, decanediol, L-carnitine, and salicylic acid may be beneficial in alternative treatment of acne in maintenance phase. This study aims to evaluate the efficacy and safety of moisturizer containing the active ingredients of licochalcone A, decanediol, L-carnitine, and salicylic acid during the maintenance …

  • 0 views
  • 25 Mar, 2025
  • 1 location
Featured trial
A5418 Study of Tecovirimat for Human Monkeypox Virus (STOMP)  

You must have a positive laboratory test for monkeypox virus within 14 days of enrolling in the study and at least one skin lesion. Participants with severe disease, significant skin conditions, participants with severe immune suppression will receive open-label tecovirimat.

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease Symptoms

Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes painful lesions in the axilla (underarm), inguinal (groin) and anogenital (anal and genital) regions. This study will evaluate how well upadacitinib compared to placebo (no medicine) works to treat hidradenitis suppurativa (HS) in adult participants with moderate to severe disease.

  • 0 views
  • 19 Feb, 2024
Moisturizer Containing Licochalcone A, Decanediol, L-carnitine and Salicylic Acid in Reducing Relapsing of Acne  

Moisturizer containing the active ingredients of licochalcone A, decanediol, L-carnitine, and salicylic acid may be beneficial in alternative treatment of acne in maintenance phase. This study aims to evaluate the efficacy and safety of moisturizer containing the active ingredients of licochalcone A, decanediol, L-carnitine, and salicylic acid during the maintenance …

  • 0 views
  • 21 Mar, 2025
  • 2 locations
Histopathologic Effect of Calcium Electroporation on Cancer in the Skin

In this phase II study we investigate the effect of calcium electroporation on cancer in the skin investigated by histopathology.

metastasis
calcium
cancer
hormone therapy
endocrine therapy
  • 0 views
  • 19 Feb, 2024
Tissue-engineered Skin Graft Repair of Autologous Scar Dermal Scaffolds

It affects the appearance and some scar contracture often leads to joint dysfunction.Patients have low quality of life, long treatment cycle, heavy social burden and high medical costs.Skin grafting is currently the gold standard for scar repair.However, there are often insufficient skin sources, easy to scar recurrence, lack of skin

hypertrophic scar
skin damage
treatment guidelines
hypertrophy
deficiency
  • 0 views
  • 19 Feb, 2024
A Study to Investigate Nicotinic Acid on VEGFR Inhibitor-Associated Hand-Foot Skin Reactions

Hand-Foot Skin Reaction (HFSR) is a common adverse event induced by Vascular Endothelial Growth Receptor Inhibitor (VEGFRi) in cancer patients. The main purpose of this study is to evaluate the efficacy and safety of nicotinic acid in solid tumor patients with grade II/III VEGFRi-associated HFSR.

  • 0 views
  • 19 Feb, 2024